-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Haemonetics, Maintains $84 Price Target

Benzinga·06/17/2026 10:00:29
Listen to the news
BTIG analyst Marie Thibault reiterates Haemonetics (NYSE:HAE) with a Buy and maintains $84 price target.